Rocky Mountain Laboratories

Rocky Mountain Laboratories (RML) is part of the NIH Intramural Research Program and is located in Hamilton, Montana. Operated by the National Institute of Allergy and Infectious Diseases, RML conducts research on maximum containment pathogens such as Ebola as well as research on prions and intracellular pathogens such as Coxiella burnetti and Francisella tularensis.[2][3][4] RML operates one of the few Biosafety level 4 laboratories in the United States, as well as Biosafety level 3 and ABSL3/4 laboratories.[5]

Rocky Mountain Laboratories
Agency overview
Formed1928 (1928)[1]
Preceding agency
  • Hygienic Laboratory
HeadquartersHamilton, Montana
Employees400[1]
Parent agencyNational Institute of Allergy and Infectious Disease, National Institutes of Health, United States Department of Health & Human Services
Website

It has been claimed[6] that during the 1950s-1990s US-Soviet "Cold War" staff at the lab (in collaboration with US military bioweapons personnel at Fort Detrick, Maryland) researched, pilot tested, and led efforts to weaponize Lyme disease through ticks. It has been suggested that the current Lyme disease epidemic which has haunted hundreds of thousands of people in the US and worldwide ever since, may be linked to such experiments.[6][7]

References
  1. "Rocky Mountain Laboratories Overview, NIAID, NIH". niaid.nih.gov. Retrieved 2016-10-28.
  2. "Heinz Feldmann, M.D., Ph.D., Laboratory of Virology". niaid.nih.gov. Retrieved 2016-10-28.
  3. "Laboratory of Bacteriology". niaid.nih.gov. Retrieved 2016-10-28.
  4. "Bruce W. Chesebro, M.D., Laboratory of Persistent Viral Diseases, NIAID, NIH". niaid.nih.gov. Retrieved 2016-10-28.
  5. "Rocky Mountain Laboratories". niaid.nih.gov. Retrieved 2016-10-28.
  6. Lel, Dorothy Kupcha (2019-07-13). "Is Lyme disease a bioweapons experiment gone bad?". LymeDisease.org Member Community. Retrieved 2019-11-25.
  7. ""Bitten" Book Review". Lyme Disease Association. 2019-05-15. Retrieved 2019-11-27.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.